Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
SBMFF:OTCMKTS
Sino Biopharmaceutical Ltd
$0.76
0.00%
(0.00) 1D
Apr 15, 11:31:08 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SBMFF...
Mkt. cap
102.72B
Avg. vol.
171.00
Volume
0.00
52-wk high
$1.24
52-wk low
$0.49
Beta
0.70
Shares outstanding
18.75B
No. of employees
21K
News stories
From sources across the web
Profile
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
CEOLi Yi
Employees21.4K
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitesbpgroup.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
8.79B
8.79B
7.13B
7.13B
Cost of goods sold
1.54B
1.54B
1.31B
1.31B
Cost of revenue
1.54B
1.54B
1.31B
1.31B
Research and development expenses
-
-
2.93B
2.93B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.77B
3.77B
2.80B
2.80B
Operating expense
5.54B
5.54B
4.38B
4.38B
Total operating expenses
7.08B
7.08B
5.69B
5.69B
Operating income
1.70B
1.70B
1.44B
1.44B
Other non operating income
40.54M
40.54M
97.99M
97.99M
EBT including unusual items
2.98B
2.98B
488.22M
488.22M
EBT excluding unusual items
2.72B
2.72B
1.55B
1.55B
Income tax expense
490.66M
490.66M
323.77M
323.77M
Effective tax rate
16.45%
16.45%
66.32%
66.32%
Other operating expenses
1.77B
1.77B
-1.35B
-1.35B
Net income
1.69B
1.69B
-522.62M
-522.62M
Net profit margin
19.28%
19.28%
-7.33%
-7.33%
Earnings per share
-
-
-
-
Interest and investment income
989.64M
989.64M
196.36M
196.36M
Interest expense
-61.60M
-61.60M
-77.56M
-77.56M
Net interest expenses
928.03M
928.03M
118.80M
118.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.97B
1.97B
1.71B
1.71B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer